Cypher

Drug Eluting Stent (DES), sirolimus-eluting coronary stent system, designed with an intricate repeat-pattern that allows for the uniform release of a unique anti-rejection-type medicine (sirolimus) that helps to limit the overgrowth of normal cells on the arterial wall during the healing process, thus reducing the risk of re-blockage (restenosis) of the treated artery, a stent system that has been proven in practice and has been studied longer than any other drug-eluting stent system and showing unsurpassed efficacy.